Research ExplorerPublicationsThe patient benefit index: a novel approach in patient-defin...

The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases.

Standard

The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. / Augustin, Matthias; Radtke, Marc; Zschocke, Ina; Blome, Christine; Behechtnejad, Julia; Schäfer, Ines; Reusch, Michael; Mielke, Volker; Rustenbach, Stephan Jeff.

In: ARCH DERMATOL RES, Vol. 301(8), 2009, p. 561-571.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Augustin, M, Radtke, M, Zschocke, I, Blome, C, Behechtnejad, J, Schäfer, I, Reusch, M, Mielke, V & Rustenbach, SJ 2009, 'The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases.', ARCH DERMATOL RES, vol. 301(8), pp. 561-571. <http://www.ncbi.nlm.nih.gov/pubmed/19326133?dopt=Citation>

APA

Augustin, M., Radtke, M., Zschocke, I., Blome, C., Behechtnejad, J., Schäfer, I., Reusch, M., Mielke, V., & Rustenbach, S. J. (2009). The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. ARCH DERMATOL RES, 301(8), 561-571. http://www.ncbi.nlm.nih.gov/pubmed/19326133?dopt=Citation

Vancouver

Augustin M, Radtke M, Zschocke I, Blome C, Behechtnejad J, Schäfer I et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. ARCH DERMATOL RES. 2009;301(8):561-571.

Bibtex

@article{820914992cc74392a1083dd73300e040,
title = "The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases.",
abstract = "Evaluation of therapeutic benefits from the patient's perspective is important in medical decision-making and reimbursement. This study aimed at developing and validating an instrument on patient-defined needs and benefits in dermatology. The questionnaire was developed according to international guidelines. The benefit assessment consists of two steps: before treatment, every patient defines his treatment needs according to a standardized list. After treatment, the patient rates the degree of benefits achieved. A {"}patient benefit index{"} (PBI) is calculated by averaging the preference-weighed results of all items. The PBI questionnaire was validated in a sample of 500 patients with ten skin diseases and in a treatment study on 906 patients with acne. The patients defined a broad spectrum of needs and treatment benefits, indicating disease-specific patterns. The PBI showed good feasibility, reliability (Cronbach's alpha >0.91) and construct validity, high responsiveness, and discrimination between subgroups. The PBI permits valid evaluation of patient-relevant benefits in dermatological treatment.",
author = "Matthias Augustin and Marc Radtke and Ina Zschocke and Christine Blome and Julia Behechtnejad and Ines Sch{\"a}fer and Michael Reusch and Volker Mielke and Rustenbach, {Stephan Jeff}",
year = "2009",
language = "Deutsch",
volume = "301(8)",
pages = "561--571",
journal = "ARCH DERMATOL RES",
issn = "0340-3696",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases.

AU - Augustin, Matthias

AU - Radtke, Marc

AU - Zschocke, Ina

AU - Blome, Christine

AU - Behechtnejad, Julia

AU - Schäfer, Ines

AU - Reusch, Michael

AU - Mielke, Volker

AU - Rustenbach, Stephan Jeff

PY - 2009

Y1 - 2009

N2 - Evaluation of therapeutic benefits from the patient's perspective is important in medical decision-making and reimbursement. This study aimed at developing and validating an instrument on patient-defined needs and benefits in dermatology. The questionnaire was developed according to international guidelines. The benefit assessment consists of two steps: before treatment, every patient defines his treatment needs according to a standardized list. After treatment, the patient rates the degree of benefits achieved. A "patient benefit index" (PBI) is calculated by averaging the preference-weighed results of all items. The PBI questionnaire was validated in a sample of 500 patients with ten skin diseases and in a treatment study on 906 patients with acne. The patients defined a broad spectrum of needs and treatment benefits, indicating disease-specific patterns. The PBI showed good feasibility, reliability (Cronbach's alpha >0.91) and construct validity, high responsiveness, and discrimination between subgroups. The PBI permits valid evaluation of patient-relevant benefits in dermatological treatment.

AB - Evaluation of therapeutic benefits from the patient's perspective is important in medical decision-making and reimbursement. This study aimed at developing and validating an instrument on patient-defined needs and benefits in dermatology. The questionnaire was developed according to international guidelines. The benefit assessment consists of two steps: before treatment, every patient defines his treatment needs according to a standardized list. After treatment, the patient rates the degree of benefits achieved. A "patient benefit index" (PBI) is calculated by averaging the preference-weighed results of all items. The PBI questionnaire was validated in a sample of 500 patients with ten skin diseases and in a treatment study on 906 patients with acne. The patients defined a broad spectrum of needs and treatment benefits, indicating disease-specific patterns. The PBI showed good feasibility, reliability (Cronbach's alpha >0.91) and construct validity, high responsiveness, and discrimination between subgroups. The PBI permits valid evaluation of patient-relevant benefits in dermatological treatment.

M3 - SCORING: Zeitschriftenaufsatz

VL - 301(8)

SP - 561

EP - 571

JO - ARCH DERMATOL RES

JF - ARCH DERMATOL RES

SN - 0340-3696

ER -